Interparfums Details Executive Pay, Equity Awards in Latest Filing

TL;DR

**IPAR's executive compensation is heavily tied to equity, signaling management's long-term commitment, but watch for dilution.**

AI Summary

INTERPARFUMS INC's DEF 14A filing for the fiscal year ended December 31, 2024, highlights executive compensation and governance. While specific revenue and net income figures are not detailed in this excerpt, the filing indicates a focus on executive remuneration for key personnel like Jean Madar, Philippe Benacin, and Philippe Santi. The company's strategic outlook appears stable, with no immediate major business changes or significant new risks disclosed beyond standard operational considerations. Compensation for Jean Madar, as a named executive officer (PEO), includes an exclusion of stock and option awards and an inclusion of equity values for 2024. Non-PEO NEOs also saw average exclusion of option awards and inclusion of equity values in 2024. The filing details the year-end fair value of unvested equity awards granted during 2024 and the change in fair value of unvested equity awards from the prior year, indicating ongoing equity-based incentives. The vesting date fair value of equity awards that vested during 2024 is also reported, demonstrating the realization of prior compensation grants.

Why It Matters

This DEF 14A filing provides crucial transparency into INTERPARFUMS INC's executive compensation structure, directly impacting investor confidence and shareholder value. Understanding how executives like Jean Madar are incentivized through equity awards helps investors assess alignment between management and shareholder interests. For employees, the compensation practices of top leadership can influence overall company culture and morale. In the competitive luxury fragrance market, attracting and retaining top talent is paramount, and compensation practices are a key component of this strategy. The disclosure allows for comparison with peers in the perfumes and cosmetics industry, such as Estée Lauder or L'Oréal, regarding governance and compensation best practices.

Risk Assessment

Risk Level: low — The filing primarily concerns executive compensation and governance, not operational or financial risks. While equity awards can lead to dilution, the document does not present new, material risks to INTERPARFUMS INC's business operations or financial stability. The detailed disclosure of compensation practices for Jean Madar and other executives suggests standard corporate governance.

Analyst Insight

Investors should analyze the equity award components for Jean Madar and other executives to understand the long-term incentive structure and potential dilution. Evaluate these compensation figures against INTERPARFUMS INC's financial performance and industry benchmarks to ensure alignment and responsible governance. Consider the impact of these awards on future earnings per share.

Executive Compensation

Key Numbers

• 2024 — Fiscal Year End (period covered by the DEF 14A filing)
• 0000822663 — Central Index Key (CIK) (unique identifier for INTERPARFUMS INC)
• 251156268 — Film Number (SEC internal tracking number for the filing)
• 1934 Act — SEC Act (governing act for the DEF 14A filing)
• 000-16469 — SEC File Number (registration number for INTERPARFUMS INC)

Key Players & Entities

• INTERPARFUMS INC (company) — filer of DEF 14A
• Jean Madar (person) — Named Executive Officer (PEO)
• Philippe Benacin (person) — Non-PEO NEO
• Philippe Santi (person) — Non-PEO NEO
• Russell Greenberg (person) — Non-PEO NEO
• Frederic Garcia Pelayo (person) — Non-PEO NEO
• Michel Atwood (person) — Non-PEO NEO
• SEC (regulator) — recipient of DEF 14A filing
• Bloomberg (company) — financial news outlet
• December 31, 2024 (date) — fiscal year end

FAQ

Industry Context

Interparfums Inc. operates in the fragrance and cosmetics industry, a sector characterized by strong brand loyalty and the importance of intellectual property. The competitive landscape includes both established luxury houses and emerging niche brands, with success often driven by marketing, distribution partnerships, and product innovation. Trends include a growing demand for sustainable and clean beauty products, as well as the continued influence of social media and influencer marketing.

Regulatory Implications

As a publicly traded company, Interparfums Inc. is subject to SEC regulations, including the timely and accurate filing of documents like the DEF 14A. Compliance with accounting standards and disclosure requirements is critical to maintain investor confidence and avoid penalties. Changes in accounting for stock-based compensation or executive pay regulations could impact future reporting.

What Investors Should Do

1. Review executive compensation details
2. Assess equity award valuations
3. Monitor governance disclosures

Key Dates

• 2024-12-31: Fiscal Year End — Marks the end of the reporting period for the DEF 14A filing.
• 2025-07-28: Filing Date — The date the DEF 14A filing was submitted to the SEC.

Glossary

DEF 14A

A proxy statement filed by public companies with the SEC detailing information about executive compensation, board of directors, and other corporate governance matters. (This filing provides insights into how Interparfums Inc. compensates its top executives and its governance structure.)

PEO

Principal Executive Officer, typically the Chief Executive Officer (CEO) of a company. (Identifies the highest-ranking executive officer, Jean Madar, and details specific compensation considerations for this role.)

NEO

Named Executive Officer, refers to the top executive officers of a company whose compensation is disclosed in SEC filings. (The filing details compensation elements for Interparfums' key executives, including both the PEO and other NEOs.)

Equity Awards

Awards of company stock or stock options granted to employees as part of their compensation. (The filing discusses the inclusion or exclusion of stock and option awards and the fair value of unvested and vested equity awards, indicating their importance in executive remuneration.)

Fair Value of Equity Awards

The estimated market value of stock or stock options granted as compensation, often calculated using valuation models. (This metric is used to quantify the value of equity-based compensation for executives, both when granted and when vested.)

Unvested Equity Awards

Equity awards that have been granted but have not yet met the conditions (e.g., time-based vesting) for the recipient to own them outright. (The filing tracks the year-end fair value and changes in fair value of these awards, showing ongoing incentive structures.)

Vesting Date Fair Value

The fair value of equity awards on the date they become fully exercisable or owned by the recipient. (Represents the realized value of equity compensation for executives upon meeting vesting requirements.)

Year-Over-Year Comparison

This DEF 14A filing for the fiscal year ended December 31, 2024, focuses on executive compensation and governance. Specific financial performance metrics like revenue and net income are not detailed in this excerpt, making a direct year-over-year comparison of these key financial highlights impossible based on this document alone. However, the compensation disclosures indicate a continued emphasis on equity-based incentives for both the PEO and other Named Executive Officers, with specific reporting on the fair value of awards granted, unvested, and vested during the year.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on July 28, 2025 by Jean Madar regarding INTERPARFUMS INC (IPAR).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR